GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 35 filers reported holding GLAXOSMITHKLINE PLC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $15,992,000 | -0.8% | 367,382 | -0.8% | 2.57% | +14.9% |
| Q1 2022 | $16,125,000 | -3.4% | 370,182 | -2.2% | 2.23% | -2.7% |
| Q4 2021 | $16,690,000 | +9.8% | 378,458 | -4.8% | 2.30% | +11.0% |
| Q3 2021 | $15,195,000 | -27.2% | 397,658 | -24.2% | 2.07% | -24.0% |
| Q2 2021 | $20,885,000 | +10.8% | 524,473 | -0.7% | 2.72% | +7.6% |
| Q1 2021 | $18,850,000 | +25.0% | 528,173 | +28.9% | 2.53% | +8.2% |
| Q4 2020 | $15,078,000 | -1.8% | 409,716 | +0.4% | 2.34% | -26.5% |
| Q3 2020 | $15,356,000 | -9.3% | 407,967 | -1.7% | 3.18% | -23.1% |
| Q2 2020 | $16,923,000 | +4.7% | 414,900 | -2.7% | 4.13% | -3.6% |
| Q1 2020 | $16,157,000 | +10.2% | 426,425 | +36.7% | 4.29% | +69.9% |
| Q4 2019 | $14,655,000 | +7.6% | 311,875 | -2.2% | 2.52% | +2.0% |
| Q3 2019 | $13,617,000 | +9.3% | 319,050 | +2.5% | 2.47% | +12.9% |
| Q2 2019 | $12,455,000 | +20.9% | 311,225 | +26.3% | 2.19% | +17.5% |
| Q1 2019 | $10,301,000 | +34.3% | 246,500 | +22.8% | 1.86% | +20.6% |
| Q4 2018 | $7,669,000 | +77.5% | 200,700 | +86.6% | 1.55% | +97.1% |
| Q3 2018 | $4,320,000 | +48.1% | 107,535 | +48.7% | 0.78% | +42.5% |
| Q2 2018 | $2,916,000 | -2.0% | 72,335 | -5.0% | 0.55% | -4.2% |
| Q1 2018 | $2,975,000 | +16.2% | 76,135 | +5.5% | 0.58% | +12.5% |
| Q4 2017 | $2,560,000 | -65.0% | 72,160 | -59.9% | 0.51% | -64.1% |
| Q3 2017 | $7,306,000 | +21.8% | 179,958 | +29.3% | 1.42% | +19.6% |
| Q2 2017 | $6,000,000 | +11.7% | 139,158 | +9.2% | 1.19% | +7.3% |
| Q1 2017 | $5,371,000 | +14.6% | 127,388 | +4.7% | 1.11% | +13.1% |
| Q4 2016 | $4,685,000 | -37.1% | 121,648 | -29.5% | 0.98% | -35.9% |
| Q3 2016 | $7,443,000 | -6.0% | 172,582 | -5.5% | 1.53% | -5.8% |
| Q2 2016 | $7,914,000 | +0.4% | 182,592 | -6.1% | 1.62% | -12.1% |
| Q1 2016 | $7,882,000 | -13.4% | 194,375 | -13.8% | 1.85% | -8.0% |
| Q4 2015 | $9,097,000 | -9.3% | 225,455 | -13.6% | 2.01% | -15.5% |
| Q3 2015 | $10,028,000 | -10.8% | 260,805 | -3.4% | 2.38% | +12.4% |
| Q2 2015 | $11,244,000 | -5.6% | 269,975 | +4.6% | 2.12% | -6.5% |
| Q1 2015 | $11,916,000 | +18.1% | 258,200 | +9.3% | 2.26% | +19.2% |
| Q4 2014 | $10,092,000 | -1.0% | 236,130 | +6.5% | 1.90% | -3.1% |
| Q3 2014 | $10,191,000 | -7.5% | 221,695 | +7.6% | 1.96% | -2.6% |
| Q2 2014 | $11,022,000 | +4.9% | 206,105 | +4.8% | 2.01% | +3.4% |
| Q1 2014 | $10,505,000 | +3.4% | 196,611 | +3.3% | 1.95% | +0.3% |
| Q4 2013 | $10,163,000 | +4.4% | 190,356 | -1.9% | 1.94% | -2.1% |
| Q3 2013 | $9,732,000 | -0.4% | 193,980 | -0.8% | 1.98% | -2.9% |
| Q2 2013 | $9,775,000 | – | 195,620 | – | 2.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |